[Percutaneous absorption of prednisolone 17-valerate-21-acetate, a new corticosteroid for topical use].
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000031:analogs & derivatives; D011565:Psoriasis / Q000188:drug therapy; D012869:Skin Absorption; D012871:Skin Diseases / Q000188:drug therapy*; D014631:Valerates / Q000378:metabolism / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D014631:Valerates; D011239:Prednisolone
Assorbimento percutaneo del prednisolone 17-valerianato-21-acetato un nuovo corticosteroide per uso topico.